In Other Journals

Ann Gregory
Med J Aust 2006; 184 (1): . || doi: 10.5694/j.1326-5377.2006.tb00097.x
Published online: 2 January 2006

Dual antiplatelet therapy, with clopidogrel added to aspirin, presents a major advance with clear benefit in managing patients with acute myocardial infarction, according to a US expert.1 Sabatine, from the Thrombolysis in Myocardial Infarction (TIMI) Study Group, was commenting on findings from COMMIT — the ClOpidogrel and Metoprolol in Myocardial Infarction Trial; also known as the Second Chinese Cardiac Study.2,3

  • Ann Gregory



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.